Healthcare | October 11, 2021
HealthEdge opens its facility in Pune
The Pune centre expands its presence beyond Bangalore and Hyderabad
The Pune centre expands its presence beyond Bangalore and Hyderabad
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Tezepelumab has been granted Orphan Drug Designation (ODD) in the US by the U.S. Food and Drug Administration (FDA) for the treatment of eosinophilic esophagitis (EoE)
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
Quantitative restrictions in place to meet domestic needs to cater to the vaccination programme
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
The applicants will only have to get their Good Manufacturing Practices certification validated every five years to retain their licence
The agreement will sharpen Cigna's focus on the growth path for its rapidly expanding global health portfolio
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
